BNSF Railway is focusing on boosting its merchandise network efficiency by reducing terminal dwell, increasing service frequency, and improving short line connections. Terminal dwell improved by 17% in the second quarter, with a 5% volume increase on Short Line Select railroads. The goal is to enhance velocity and reduce transit times for customers.

To further enhance customer service, BNSF introduced a First Mile/Last Mile group to better understand customer needs and collaborate on supply chain solutions. The Short Line Select program aims to strengthen partnerships with top connecting railroads, focusing on strategic relationships rather than transactions. Last year, BNSF handled 2.43 million merchandise carloads, excluding coal and grain shipments.

BNSF is expanding its Premier Transload Program directory to include shortline locations and adding rail-served properties to its Certified Sites for development. The railroad plans to enhance technology tools for customer interaction to further streamline operations. The goal is to provide efficient and effective rail services to meet customer needs and drive growth. 1. The stock market surged today with the S&P 500 reaching a new all-time high of 4,500, driven by strong corporate earnings reports. Tech stocks led the gains, with Apple, Amazon, and Microsoft all seeing significant increases in their share prices.

2. In international news, the United Nations reported that over 400,000 people have been displaced by the conflict in Afghanistan this year alone. The humanitarian crisis continues to worsen as violence escalates in the region, with millions of people in need of urgent assistance.

3. On the climate front, a new study revealed that global carbon dioxide emissions have reached a record high of 36.4 billion tons in 2021. The report warns that urgent action is needed to curb emissions and prevent catastrophic climate change, with experts calling for greater investment in renewable energy sources.

4. In health news, a new breakthrough treatment for Alzheimer’s disease has shown promising results in clinical trials. The drug, known as Aduhelm, has been found to slow the progression of the disease in early-stage patients, offering hope for millions of people affected by this devastating condition.

Read more at Yahoo Finance: BNSF aims to grow carload traffic with rail service upgrades